These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 15042608

  • 1. Combination therapy with vitamins C plus E inhibits survivin and human prostate cancer cell growth.
    Gunawardena K, Campbell LD, Meikle AW.
    Prostate; 2004 May 15; 59(3):319-27. PubMed ID: 15042608
    [Abstract] [Full Text] [Related]

  • 2. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
    Gunawardena K, Campbell LD, Meikle AW.
    Cancer Detect Prev; 2005 May 15; 29(4):389-95. PubMed ID: 16139439
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 4. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M, Latham DE, Delaney MA, Chakravarti A.
    Oncogene; 2005 Apr 07; 24(15):2474-82. PubMed ID: 15735703
    [Abstract] [Full Text] [Related]

  • 5. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 6. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G, Tomasello F.
    Cancer; 2008 May 15; 112(10):2258-66. PubMed ID: 18327814
    [Abstract] [Full Text] [Related]

  • 7. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
    Song H, Xin XY, Xiao F, Wang DT, Yue QH, Han X.
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan 15; 136(1):83-9. PubMed ID: 17098350
    [Abstract] [Full Text] [Related]

  • 8. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
    Kishi H, Igawa M, Kikuno N, Yoshino T, Urakami S, Shiina H.
    J Urol; 2004 May 15; 171(5):1855-60. PubMed ID: 15076293
    [Abstract] [Full Text] [Related]

  • 9. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J, Lee YJ.
    Mol Pharmacol; 2007 Dec 15; 72(6):1586-92. PubMed ID: 17848598
    [Abstract] [Full Text] [Related]

  • 10. High selenium reduces NF-kappaB-regulated gene expression in uninduced human prostate cancer cells.
    Christensen MJ, Nartey ET, Hada AL, Legg RL, Barzee BR.
    Nutr Cancer; 2007 Dec 15; 58(2):197-204. PubMed ID: 17640166
    [Abstract] [Full Text] [Related]

  • 11. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 15; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 12. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 13. DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells.
    Liang Z, Wei S, Guan J, Luo Y, Gao J, Zhu H, Wu S, Liu T.
    J Gastroenterol Hepatol; 2005 Oct 01; 20(10):1595-602. PubMed ID: 16174080
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X, Wang S, Zhou J, Xing H, Xu G, Wang B, Chen G, Lu YP, Ma D.
    Oncol Rep; 2005 Jul 01; 14(1):275-9. PubMed ID: 15944801
    [Abstract] [Full Text] [Related]

  • 15. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H, Sen S, Mathur M, Bahadur S, Singh N.
    Head Neck; 2004 Aug 01; 26(8):733-40. PubMed ID: 15287041
    [Abstract] [Full Text] [Related]

  • 16. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
    Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M.
    Cancer Res; 2008 Mar 01; 68(5):1427-35. PubMed ID: 18316606
    [Abstract] [Full Text] [Related]

  • 17. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
    Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K.
    Urology; 2008 Dec 01; 72(6):1229-33. PubMed ID: 18336887
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A.
    Prostate; 2005 Aug 01; 64(3):293-302. PubMed ID: 15754318
    [Abstract] [Full Text] [Related]

  • 19. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA, Nikitakis NG, Sauk JJ.
    Int J Oral Maxillofac Surg; 2007 Jul 01; 36(7):632-9. PubMed ID: 17566705
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
    Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Wada M, Miyatake S, Imamura M.
    Surgery; 2005 Aug 01; 138(2):299-305. PubMed ID: 16153440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.